DRUG · Mapped RxNorm record
Desipramine
Normalized identity: desipramineView linked drug · Find medicine records ·
Find other trials using this name
Clinical trial
Desipramine for Improving Cellular Signaling and Decreasing Symptoms of Major Depression
NCT00320632
Drugs and interventions used in this trial
1 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No matching interventions in this trial.
Study at a glance
Registry-backedDesipramine for Improving Cellular Signaling and Decreasing Symptoms of Major Depression
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE4
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Depressionverified · MONDO: depressive disorder
Interventions
DesipramineDRUG · verified · RxNorm: desipramine
Sponsors & collaborators
Harvard Medical School (HMS and HSDM)lead sponsor
National Institute of Mental Health (NIMH)collaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00320632 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.